Showing results (1-10 of 196) with videos related to
Sort By:
Pageof 20
Leukemia & Lymphoma|June 14, 2003
Correlation between cell size and CD38 expression in chronic lymphocytic leukaemiaSameer Manocha, Zoltan Matrai, Michael Osthoff, et al.Blood|August 1, 2002
Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemiaKe Lin, Paul D Sherrington, Michael Dennis, et al.Cancer Research|June 4, 2009
A novel type of p53 pathway dysfunction in chronic lymphocytic leukemia resulting from two interacting single nucleotide polymorphisms within the p21 geneGillian G Johnson, Paul D Sherrington, Anthony Carter, et al.Blood|July 14, 2021
Is it time for PET-guided therapy in follicular lymphoma?Judith Trotman, Andrew R PettittHaematologica|August 29, 2009
Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibitionJianguo Zhuang, Stephen F Hawkins, Mark A Glenn, et al.European Journal of Haematology|June 18, 2011
Lenalidomide can be highly effective in chronic lymphocytic leukaemia despite T-cell depletion and deletion of chromosome 17pArvind Arumainathan, Nagesh Kalakonda, Andrew R PettittBiomed Research International|January 4, 2014
Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunctionMichael Osthoff, Marten TrendelenburgInternational Journal of Oncology|May 3, 2014
Motility and trafficking in B-cell non-Hodgkin's lymphoma (Review)Kathleen J Till, Sarah E Coupland, Andrew R PettittJournal of Immunology (Baltimore, Md. : 1950)|January 30, 2015
Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cellsKathleen J Till, Andrew R Pettitt, Joseph R SlupskyPageof 20